Larvol Delta - Carisma-Therapeutics-Granted-FDA-Fast-Track-Designation-for-CT0525-for-the-Treatment-of-HER2overexpressing-Solid-Tumors

CT-0525 - CARISMA Therap

https://www.prnewswire.com/news-releases/carisma-therapeutics-granted-fda-fast-track-designation-for-ct-0525-for-the-treatment-of-her2overexpressing-solid-tumors-302180804.html

Jun 25, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next